Providing evidence-based information in a practical, easy-to-read format for practicing clinicians, investigators, industry scientists, and other entities involved in the field of neuroscience
Current Issue • July–September 2024
Azithromycin-induced Adolescent Manic Episode with Psychotic Features: A Case Report

By |March 1, 2025|Comments Off on Azithromycin-induced Adolescent Manic Episode with Psychotic Features: A Case Report

by Amro H. Mohammad, MD, PhD; Marie-Pier Lecours, MD, PhD; Emmanuel Adams-Gelinas, BSc; Arshia Kakkar, MD; and Anthi Stefatos, MD, FRCPC Dr. Mohammad, Mr. Adams-Gelinas, and Dr. Kakkar are with the Faculty of Medicine and [...]

Risk Management: I’ve Been Sued, Now What! Part 1

By |March 1, 2025|Comments Off on Risk Management: I’ve Been Sued, Now What! Part 1

by Denita Neal, JD Ms. Neal is Senior Risk Manager of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this article. DISCLOSURES: The author is an [...]

Letter to the Editor: Schizophrenia with catatonia and stupor is an emergency and requires immediate psychiatric and neurological evaluation

By |December 1, 2024|Comments Off on Letter to the Editor: Schizophrenia with catatonia and stupor is an emergency and requires immediate psychiatric and neurological evaluation

Innov Clin Neurosci. 2024;21(10–12):8. Dear Editor: The interesting article by Zuckerberg et al1 on a 29-year-old male patient with schizophrenia, catatonia, and stupor associated with an enlarged cavum septum pellucidum (CSP), which only responded to [...]

Sociodemographic Factors and Consanguinity in Intellectual Disability: A Pilot Study

By |December 1, 2024|Comments Off on Sociodemographic Factors and Consanguinity in Intellectual Disability: A Pilot Study

by Dr. Yousra Benmakhlouf, PhD; Dr. Achraf Laghmich, PhD*; Kaoutar Ben Makhlouf, PhD*; Prof. Amina Barakat, PhD; Prof. Naima Ghailani Nourouti, PhD; and Prof. Mohcine Bennani Mechita, PhD All authors are with Intelligent Automation and [...]

Patient Challenges in Utilization of Methadone to Treat Opioid Use Disorder and Perspectives on a Solution for Improved Security and Convenience in Take-home Dosing

By |December 1, 2024|Comments Off on Patient Challenges in Utilization of Methadone to Treat Opioid Use Disorder and Perspectives on a Solution for Improved Security and Convenience in Take-home Dosing

by Eric Morse, MD; Graeme Christianson, BSE; Melissa Olivadoti, PhD; and John Timberlake, MBA  Dr. Morse is with Carolina Performance in Raleigh, North Carolina and Morse Clinics in Raleigh, North Carolina. Mr. Christianson is with [...]

Past Articles
Letter to the Editor: Responding to correspondence on “Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes”

By |June 1, 2024|

Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. Dr. Citrome is a consultant for AbbVie/Allergan, Acadia, Adamas, Alkermes, Angelini, Astellas, Avanir, Axsome, BioXcel, Boehringer Ingelheim, Cadent Therapeutics, Cerevel, Clinilabs, COMPASS, Eisai, Enteris BioPharma, HLS Therapeutics, Idorsia, INmune [...]

Letter to the Editor: Response to “Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes”

By |June 1, 2024|

Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. Dr. Zaragoza Domingo is co-author and intellectual property owner of the EPICOG-SCH battery. No funding was received for the preparation of this letter. Dear Editor: As co-author of the [...]